Aller au contenu Navigation Accès directs Connexion

Guy LAURENT - Publications

EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY

Equipe constitutive du CERPOP, UMR1295,unité mixte INSERM - Université Toulouse III Paul Sabatier




2021

  • Grèze C, Pereira B, Boirie Y, Guy L, Millet C, Clerfond G, Garrouste C, Heng AE. Impact of obesity in kidney transplantation: a prospective cohort study from French registries between 2008 and 2014. Nephrol Dial Transplant. 2021 Oct 5:gfab277. doi: 10.1093/ndt/gfab277. Epub ahead of print.
     
  • Houfaf Khoufaf FZ, Sanchez A, Idrissou M, Boisnier T, Penault-Llorca F, Bignon YJ, Guy L, Bernard-Gallon D. Role of UTX Histone Demethylase in Regulation of MGMT, TRA2A, U2AF1, and RPS6KA2 Genes in Prostate Cancer Cell Lines. OMICS. 2021 Feb;25(2):129-131. doi: 10.1089/omi.2020.0183.
     
  • Lebret T, Pignot G, Colombel M, Guy L, Rebillard X, Savareux L, Roumigue M, Nivet S, Coutade Saidi M, Piaton E, Radulescu C. Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test. BJU Int. 2021 Mar 10. doi: 10.1111/bju.15382.
     
  • Méjean A, Ravaud A, Thezenas S, Chevreau C, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Oudard S, Laguerre B, Gross-Goupil M, Bernhard JC, Colas S, Albiges L, Lebret T, Treluyer JM, Timsit MO, Escudier B. Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy? Eur Urol. 2021 Oct;80(4):417-424. doi: 10.1016/j.eururo.2021.06.009.
     
  • Pfister C, Gravis G, Fléchon A, Soulié M, Guy L, Laguerre B, Mottet N, Joly F, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses. Eur Urol. 2021 Feb;79(2):214-221. doi: 10.1016/j.eururo.2020.08.024.
     
  • Roumiguié M, Paoletti X, Neuzillet Y, Mathieu R, Vincendeau S, Kleinclauss F, Mejean A, Guy L, Timsit MO, Lebret T. Apalutamide, darolutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer: a meta-analysis. Future Oncol. 2021 May;17(14):1811-1823. doi: 10.2217/fon-2020-1104.
     
  • Sanchez A, Houfaf Khoufaf FZ, Idrissou M, Penault-Llorca F, Bignon YJ, Guy L, Bernard-Gallon D. The Functions of the Demethylase JMJD3 in Cancer. Int J Mol Sci. 2021 Jan 19;22(2):968. doi: 10.3390/ijms22020968.
     
  • Tabourin T, Pinar U, Cassagnes L, Boirie Y, Heng AE, Guandalino M, Guy L. The role of CT-scan assessment of muscle mass in predicting postoperative surgical complications after renal transplantation. Int Urol Nephrol. 2021 Dec 12. doi: 10.1007/s11255-021-03089-x. Epub ahead of print.

2020

  • Camille C, Dimeglio C, Yrondi A, Compaci G, Delmas E, Gauché M, Laurent G, Birmes P. Posttraumatic Stress Disorder Symptoms in Lymphoma Patients: A Prospective Study. Front Psychiatry. 2020 Mar 11;11:201. doi: 10.3389/fpsyt.2020.00201.
     
  • Gauthier M, Conte C, Palmaro A, Patras De Campaigno E, De Barros S, Huguet F, Laurent G, Lapeyre-Mestre M, Despas F. Psychotropic drug initiation in patients diagnosed with chronic myeloid leukemia: a population-based study in France [published online ahead of print, 2020 Feb 7]. Fundam Clin Pharmacol. 2020;10.1111/fcp.12544. doi:10.1111/fcp.12544.
     
  • El Ouardi D, Idrissou M, Sanchez A, Penault-Llorca F, Bignon YJ, Guy L, Bernard-Gallon D. The Inhibition of the Histone Methyltransferase EZH2 by DZNEP or SiRNA Demonstrates Its Involvement in MGMT, TRA2A, RPS6KA2, and U2AF1 Gene Regulation in Prostate Cancer. OMICS. 2020 Feb;24(2):116-118. doi: 10.1089/omi.2019.0162.
     
  • Mounié M, Costa N, Conte C, Petiot D, Fabre D, Despas F, Lapeyre-Mestre M, Laurent G, Savy N, Laurent Molinier L. Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France. J Med Econ. 2020;23(3):235‐242. doi:10.1080/13696998.2019.1702990.
     
  • Sanchez A, El Ouardi D, Houfaf Khoufaf FZ, Idrissou M, Boisnier T, Penault-Llorca F, Bignon YJ, Guy L, Bernard-Gallon D. Role of JMJD3 Demethylase and Its Inhibitor GSK-J4 in Regulation of MGMT, TRA2A, RPS6KA2, and U2AF1 Genes in Prostate Cancer Cell Lines. OMICS. 2020 Aug;24(8):505-507. doi: 10.1089/omi.2020.0054.
     
  • Vayr F, Montastruc M, Savall F, Despas F, Judic E, Basso M, Dunet C, Dalenc F, Laurent G, Soulat JM, Fabrice H. Work adjustments and employment among breast cancer survivors: a French prospective study. Support Care Cancer. 2020;28(1):185–192. doi:10.1007/s00520-019-04799-w.

2019

  • Berger E, Delpierre C, Despas F, Bertoli S, Bérard E, Bombarde O, Bories P, Sarry A, Laurent G, Récher C, Lamy S. Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients. BMC Cancer. 2019 Sep 5;19(1):883. doi: 10.1186/s12885-019-6093-3.
     
  • Compaci G, Conte C, Oberic L, Ysebaert L, Laurent G, Despas F. Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey. BMC Cancer. 2019;19(1):1178. doi:10.1186/s12885-019-6337-2.
     
  • De Barros S, Vayr F, Despas F, Strumia M, Podevin C, Gauthier M, Delabesse E, Soulat JM, Laurent G, Huguet F, Herin F. The impact of chronic myeloid leukemia on employment: the French prospective study. Ann Hematol. 2019 Mar;98(3):615-623. doi: 10.1007/s00277-018-3549-5.

     
  • Mounié M, Costa N, Conte C, Petiot D, Fabre D, Despas F, Lapeyre-Mestre M, Laurent G, Savy N, Molinier L. Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France. J Med Econ. 2019;1–8. doi:10.1080/13696998.2019.1702990.
     
  • Lamy S, Laurent G, Lepage B, Grosclaude P, Delpierre C. Impact of comorbidity in DBLCL: direct and indirect effects on survival through unplanned chemotherapy dose reduction. J Intern Med. 2019 Apr;285(4):472-474. doi: 10.1111/joim.12879.
     
  • Walburg V, Rueter M, Lamy S, Compaci G, Lapeyre-Mestre M, Laurent G, Despas F. Fear of cancer recurrence in Non- and Hodgkin lymphoma survivors during their first three years of survivorship among French patients. Psychol Health Med. 2019 Aug;24(7):781-787. doi: 10.1080/13548506.2019.1574354.
     
  • Ysebaert L, Larcher M, Compaci G, Oberic L, Sahnes L, Banos A, Araujo C, Sommet A, Laurent G, Despas F. Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemia. Ann Hematol. 2019 Apr;98(4):931-939. doi: 10.1007/s00277-019-03631-z.
https://cerpop.inserm.fr/guy-laurent-publications

Ce site utilise Google Analytics. En appuyant sur le bouton "j'accepte", vous nous autorisez à déposer des cookies à des fins de mesure d'audience. En savoir plus sur la manière dont nous utilisons les cookies.

Vous avez donné votre consentement pour le dépôt de cookies de mesures d'audience dans votre navigateur.

Vous vous êtes opposé au dépôt de cookies de mesures d'audience dans votre navigateur.

Le paramètre "Do Not Track" est actif sur votre navigateur. Aucunes statistiques de navigation ne seront collectées.